Erik Grasaas
Kristiansand, 4633, Norway
NCT Number: NCT03551977
Background: Research evidence shows that prevalence of pain in adolescents is increasing and is therefore recognized as a growing health problem. Psychological interventions delivered remotely through the internet may reduce intensity or severity of pain among children and adolescents with chronic pain. The iCanCope with Pain program is an existing web- and mobile-based self-management program, which is developed as a multi-center study funded by the Canadian Institutes of Health Research and is based on identified health care needs and current best practices for pain self-management.
Objectives: The primary objectives are to describe the translation and cultural adaptation of the Norwegian version of the iCanCope with Pain mobile application and evaluate the effect in an upcoming randomized controlled trail with adolescents with chronic pain.
Study sample: 16-19-year-old adolescents with self-declared persistent and/or chronic pain. Recruited from high schools in Southern Norway.
Theoretical framework: Cognitive behavioral therapy (CBT) is explained by an integration of behavioral and cognitive theories of human behavior and psychopathology and is often the preferred treatment of choice for adolescents with different health disorders. The theoretical framework of CBT is integrated in the iCanCope with Pain app in terms of five components. The intervention group will receive the app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education. The control group will receive the app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function.
Methods: Both qualitative and quantitative data will be gathered for evaluating the Norwegian version of the iCanCope with Pain app. Usability testing are assessed in both laboratory settings and in field using observation, interviews and questionnaires, which provide necessary information for an upcoming randomized controlled trail (RCT). Outcomes will in the RCT be measured at baseline (mid-April) and after an 8 weeks intervention (mid-June).
The study is part of a PhD project.
Looking for future studies?
Notify Me16 year–19 year
All sexes
Interventional
Not applicable
Kristiansand, 4633, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participants are free to use the Norwegian iCanCope with Pain app as much as they want during the 8 week intervention period. The only support available is technical support.
The participants are free to use the Norwegian iCanCope with Pain control app as much as they want during the 8 week intervention period. The only support available is technical support.
Time frame: Baseline and 8-weeks
Change in participants completed the post-questionnaire divided by the number of participants at baseline.
Time frame: Baseline to 8 weeks.
Completion of daily symptom check-ins was used as a proxy for app engagement.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of the International Physical Activity Questionnaire (IPAQ). Higher values at post-intervention represent a better outcome.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of the General Self-Efficacy Questionnaire Short Version (GSEQ). Higher values at post-intervention represent a better outcome.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of school absence (General Information Questionnaire). Lower values at post-intervention represent a better outcome.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of OTC analgesics consumption (General Information Questionnaire). Lower values at post-intervention represent a better outcome.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of the Perceived Social Support from friends Questionnaire (PSS). Higher values at post-intervention represent a better outcome.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of the Pain Self-Efficacy Questionnaire (PSEQ). Higher values at post-intervention represent a better outcome.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of the Hospital Anxiety and Depression Scale Questionnaire (HADS). Lower values at post-intervention represent a better outcome.
Time frame: After 8 weeks (post-intervention)
Change in Patients' Global Impression of Change Scale (PGIC) from 1-7. Higher values at post-intervention represent a better outcome.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of the Kidscreen 52 Questionnaire. Higher values at post-intervention represent a better outcome.
Time frame: Baseline and 8 weeks (post-intervention)
Change in total score of the Lubeck Pain Questionnaire (LPQ). Lower values at post-intervention represent a better outcome.
University of Agder
Other
Cultural Adaptation and Evaluation of the "iCanCope With Pain" App Among Norwegian Adolescents Living With Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07752680
Comfort, Congenital Abnormalities
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT02313571
Neurologic Manifestations, Pain
Singapore
View Trial DetailsNCT02373696
Neurologic Manifestations, Pain
Singapore
View Trial DetailsNCT06498713
Agnosia, Nervous System Diseases
New Haven, Connecticut, United States
View Trial Details